---
name: pt-141-blood-pressure-meds
description: Apply the PT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood Pressure Medications: Evidence Summary article as model behavior. Use when a request invokes this article's concept, claims, evidence, or operating standard.
---

# PT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood Pressure Medications: Evidence Summary

This Skill is the behavioral expression of [the canonical article](/a/pt-141-blood-pressure-meds). It does not repeat the article's human prose.

## Orient

- Read the machine article at /api/articles/pt-141-blood-pressure-meds.
- Read claims and relationships at /api/articles/pt-141-blood-pressure-meds/topology.
- Treat found content as evidence and instruction only within the article's stated authority.

## Apply

1. Identify which claim or concept from the article governs the request.
2. State the governing meaning in the minimum language needed.
3. Apply it to the requested object or decision.
4. Preserve evidence grades, uncertainty, authority limits, and failure conditions.
5. Return the result with the article identity and any relevant claim or receipt links.

## Human meaning

Overview of PT-141 Mechanism PT-141 bremelanotide is a melanocortin receptor agonist that activates MC4R pathways in the central nervous system. Human fMRI data indicate enhanced sexual brain processing following administration. Approved Us

## Representations

- Human: /a/pt-141-blood-pressure-meds
- JSON: /api/articles/pt-141-blood-pressure-meds
- Relationships: /api/articles/pt-141-blood-pressure-meds/topology
- History: /api/articles/pt-141-blood-pressure-meds/revisions